RxDoctor Payments Data

David Hirsch, DDS

Oral and Maxillofacial Surgery · New York, NYNPI 1124038427

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $34,000 of the $46,026 with a category attached, or 73.9%. Stryker accounts for 98.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $37,730 and has fallen 98.7% since, to $482 in 2024. Among oral and maxillofacial surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,026in general payments, 2019–2025

Across 52 payments — averaging $885.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$45K
  • Straumann USA LLC$710
  • Axogen$91
  • Kls-martin L.p.$89
  • SS White Burs LLC$26
  • Vertical Pharmaceuticals, LLC$11

What the payments were for

  • Consulting fees$34,00074%
  • Travel & lodging$10,64223%
  • Food & beverage$9112%
  • Gifts$50%
  • Other$4681%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,026 in reported general payments places this provider in the 95th percentile of 605 oral and maxillofacial surgery providers in New York.

See all oral and maxillofacial surgery providers in New York

Medicare billing

Part B allowed, 2024
$53,629
Medicare patients
95
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinonide16$840
Oxycodone Hcl34$229
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$88
Amoxicillin16$45

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →